Stelvio Therapeutics Company
Stelvio Oncology is focused on delivering precision medicine diagnostics and novel therapeutics for glioblastoma.
Investors
Founded Date:
2017-03-01
Technology:
['BioTech & HealthTech']
Investor Type:
For Profit
Funding Status:
Seed
Employee Number:
11-50
Headquarters:
San Diego, California, United States
Last Funding Date:
2017-05-05
Investors Number:
2.0
Last Funding Type:
Seed
Estimated Revenue:
Less than $1M
Industry:
Medical BioTech